Four out of 10 eczema patients struggle with sleep, and they may not volunteer that information unless you ask.

More than one in four U.S. adults with diabetes used one of the injectable medicines that target the GLP-1 protein last year, the U.S. Centers for Disease Control and Prevention said on Thursday. The ...